The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
about
Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population.CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.A multicenter study of cancer incidence in CHEK2 1100delC mutation carriersCHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.
P2860
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
@ast
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
@en
type
label
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
@ast
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
@en
prefLabel
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
@ast
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
@en
P2093
P2860
P356
P1476
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601551
P407
P577
2004-02-01T00:00:00Z